Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Leukemia

  Free Subscription


Articles published in Oncogene

Retrieve available abstracts of 25 articles:
HTML format
Text format



Single Articles


    April 2017
  1. MADAPURA HS, Nagy N, Ujvari D, Kallas T, et al
    Interferon gamma is a STAT1-dependent direct inducer of BCL6 expression in imatinib-treated chronic myeloid leukemia cells.
    Oncogene. 2017 Apr 3. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


  2. SOCHALSKA M, Schuler F, Weiss JG, Prchal-Murphy M, et al
    MYC selects against reduced BCL2A1/A1 protein expression during B cell lymphomagenesis.
    Oncogene. 2017;36:2066-2073.
    PubMed     Text format     Abstract available


    March 2017
  3. TAKAHASHI H, Inoue J, Sakaguchi K, Takagi M, et al
    Autophagy is required for cell survival under L-asparaginase-induced metabolic stress in acute lymphoblastic leukemia cells.
    Oncogene. 2017 Mar 27. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


  4. FERREIRA HJ, Heyn H, Vizoso M, Moutinho C, et al
    DNMT3A mutations mediate the epigenetic reactivation of the leukemogenic factor MEIS1 in acute myeloid leukemia.
    Oncogene. 2017 Mar 13. doi: 10.1038/onc.2017.
    PubMed     Text format    


    February 2017
  5. VAN ATTEKUM MH, Terpstra S, Slinger E, von Lindern M, et al
    Macrophages confer survival signals via CCR1-dependent translational MCL-1 induction in chronic lymphocytic leukemia.
    Oncogene. 2017 Feb 13. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


  6. WAKIM J, Arman E, Becker-Herman S, Kramer MP, et al
    The PTPROt tyrosine phosphatase functions as an obligate haploinsufficient tumor suppressor in vivo in B-cell chronic lymphocytic leukemia.
    Oncogene. 2017 Feb 6. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


    January 2017
  7. PRANGE KH, Mandoli A, Kuznetsova T, Wang SY, et al
    MLL-AF9 and MLL-AF4 oncofusion proteins bind a distinct enhancer repertoire and target the RUNX1 program in 11q23 acute myeloid leukemia.
    Oncogene. 2017 Jan 23. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


  8. UGALE A, Sawen P, Dudenhoffer-Pfeifer M, Wahlestedt M, et al
    MLL-ENL-mediated leukemia initiation at the interface of lymphoid commitment.
    Oncogene. 2017 Jan 9. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


    December 2016
  9. POMEROY EJ, Lee LA, Lee RD, Schirm DK, et al
    Ras oncogene-independent activation of RALB signaling is a targetable mechanism of escape from NRAS(V12) oncogene addiction in acute myeloid leukemia.
    Oncogene. 2016 Dec 19. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


    November 2016
  10. SAFFERTHAL C, Rohde K, Fulda S
    Therapeutic targeting of necroptosis by Smac mimetic bypasses apoptosis resistance in acute myeloid leukemia cells.
    Oncogene. 2016 Nov 21. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


  11. GOYAMA S, Shrestha M, Schibler J, Rosenfeldt L, et al
    Protease-activated receptor-1 inhibits proliferation but enhances leukemia stem cell activity in acute myeloid leukemia.
    Oncogene. 2016 Nov 7. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


    September 2016
  12. SMITH CI
    From identification of the BTK kinase to effective management of leukemia.
    Oncogene. 2016 Sep 26. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


  13. STAFFAS A, Arabanian LS, Wei SY, Jansson A, et al
    Upregulation of Flt3 is a passive event in Hoxa9/Meis1-induced acute myeloid leukemia in mice.
    Oncogene. 2016 Sep 12. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


  14. HU Y, Su H, Liu C, Wang Z, et al
    DEPTOR is a direct NOTCH1 target that promotes cell proliferation and survival in T-cell leukemia.
    Oncogene. 2016 Sep 5. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


  15. LEE-SHERICK AB, Eisenman KM, Sather S, McGranahan A, et al
    Aberrant Mer receptor tyrosine kinase expression contributes to leukemogenesis in acute myeloid leukemia.
    Oncogene. 2016 Sep 5. doi: 10.1038/onc.2016.
    PubMed     Text format    


    June 2016
  16. ELF S, Lin R, Xia S, Pan Y, et al
    Targeting 6-phosphogluconate dehydrogenase in the oxidative PPP sensitizes leukemia cells to antimalarial agent dihydroartemisinin.
    Oncogene. 2016 Jun 6. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


    May 2016
  17. BERNASCONI-ELIAS P, Hu T, Jenkins D, Firestone B, et al
    Characterization of activating mutations of NOTCH3 in T-cell acute lymphoblastic leukemia and anti-leukemic activity of NOTCH3 inhibitory antibodies.
    Oncogene. 2016 May 9. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


    April 2016
  18. SU R, Dong L, Zou D, Zhao H, et al
    microRNA-23a, -27a and -24 synergistically regulate JAK1/Stat3 cascade and serve as novel therapeutic targets in human acute erythroid leukemia.
    Oncogene. 2016 Apr 18. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


  19. LIU PP, Liu J, Jiang WQ, Carew JS, et al
    Elimination of chronic lymphocytic leukemia cells in stromal microenvironment by targeting CPT with an antiangina drug perhexiline.
    Oncogene. 2016 Apr 11. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


    February 2016
  20. SLANY RK
    The molecular mechanics of mixed lineage leukemia.
    Oncogene. 2016 Feb 29. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


    January 2016
  21. RODRIGUEZ-PERALES S, Torres-Ruiz R, Suela J, Acquadro F, et al
    Truncated RUNX1 protein generated by a novel t(1;21)(p32;q22) chromosomal translocation impairs the proliferation and differentiation of human hematopoietic progenitors.
    Oncogene. 2016;35:125-34.
    PubMed     Text format     Abstract available


  22. WIMMER P, Berscheminski J, Blanchette P, Groitl P, et al
    PML isoforms IV and V contribute to adenovirus-mediated oncogenic transformation by functionally inhibiting the tumor-suppressor p53.
    Oncogene. 2016;35:69-82.
    PubMed     Text format     Abstract available


    December 2015
  23. ZHAO Y, Masiello D, McMillian M, Nguyen C, et al
    CBP/catenin antagonist safely eliminates drug-resistant leukemia-initiating cells.
    Oncogene. 2015 Dec 14. doi: 10.1038/onc.2015.
    PubMed     Text format     Abstract available


    November 2015
  24. MARJON KD, Termini CM, Karlen KL, Saito-Reis C, et al
    Tetraspanin CD82 regulates bone marrow homing of acute myeloid leukemia by modulating the molecular organization of N-cadherin.
    Oncogene. 2015 Nov 23. doi: 10.1038/onc.2015.
    PubMed     Text format     Abstract available


    September 2015
  25. SHAIN KH, Dalton WS, Tao J
    The tumor microenvironment shapes hallmarks of mature B-cell malignancies.
    Oncogene. 2015;34:4673-82.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Leukemia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: